Global Breast Cancer Therapeutics Market
Breast Cancer Therapeutics Market Size And Forecast
According to Verified Market Research, Global Breast Cancer Therapeutics Market was valued at USD 16.9 Billion in 2018 and is projected to reach USD 35.9 Billion by 2026, growing at a CAGR of 9.7% from 2019 to 2026.
Global Breast Cancer Therapeutics Market Outlook
The global breast cancer therapeutics market is driven by the rising prevalence of breast cancer pertaining to factors such as early menarche, prolonged exposure to endogenous oestrogens, late age at first childbirth and late menopause. Also, a rise in research and development funding for innovative drugs, high frequency of CSR activities carried out by corporates for awareness of breast cancer, mergers and acquisition are some other key factors propelling the market growth. Moreover, the growing adoption of therapeutics owing to factors such as blocking estrogenic from binding to tumor cells, risk of distant appearance, and reducing the risk of developing the disease in another breast are further expected to propel the growth of the market. On the other hand, increasing the cost of early and late-stage disease therapy, the prohibitive cost associated with the use of breast cancer therapeutics might hinder the growth of the market.
Global Breast Cancer Therapeutics Market Competitive Landscape
The Global Breast Cancer Therapeutics Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as AstraZeneca plc, Eisai Co. Ltd., Eli Lilly and Company, Roche Diagnostics, Novartis AG, Pfizer Inc., Celgene, Sanofi S.A., Teva Pharmaceutical and GlaxoSmithKline plc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.